Poliomyelitis Clinical Trials

191 clinical trials for Poliomyelitis across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama — RECRUITING · PHASE2
• Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine — RECRUITING · PHASE4
• Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations — RECRUITING · PHASE4
• Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh — RECRUITING · PHASE2
• Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation — RECRUITING · PHASE2
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series — RECRUITING · PHASE2
• Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines — RECRUITING · PHASE1
• Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly — OTHER · PHASE2
• Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine — OTHER · PHASE4
• A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers — ACTIVE_NOT_RECRUITING · PHASE1
• The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility Impairment — COMPLETED · NA
• Booster Dose of sIPV Co-administered With MMR and HepA-I. — COMPLETED · PHASE4
• Confirmatory Study of BK1310 in Healthy Infants — COMPLETED · PHASE3
• Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell) — COMPLETED · PHASE3
• A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine — COMPLETED · PHASE3
• High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners — COMPLETED · NA
• A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants — NOT_YET_RECRUITING · PHASE3
• Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis — ACTIVE_NOT_RECRUITING · NA
• Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants — COMPLETED · PHASE3
• Assessing Immunogenicity of Intramuscular Sabin Inactivated Poliovirus Vaccine and Non-inferiority of Intradermal Fractional Inactivated Poliovirus Vaccine — COMPLETED · PHASE4
• Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers — COMPLETED · PHASE4
• A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants — COMPLETED · PHASE3
• A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults — COMPLETED · PHASE1
• Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines — COMPLETED · PHASE1
• Immunogenicity nOPV2 With and Without bOPV — COMPLETED · PHASE2
• Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age — NOT_YET_RECRUITING · PHASE2
• A Study to Evaluate Pharyngeal Immunity to Poliovirus Type-2 — COMPLETED · PHASE4
• Study to Evaluate Safety and Immunogenicity of nOPV2 at Different Intervals in Infants — COMPLETED · PHASE3
• Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine — COMPLETED · NA
• Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency Immunogenicity, and Safety of the msIPV in 2 Months Old Infants — COMPLETED · PHASE3
• A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine — COMPLETED · PHASE2
• Intradermal Fractional Dose IPV (fIPV) in Combination With dmLT — OTHER · PHASE1
• Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine — COMPLETED · PHASE3
• The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV) — COMPLETED · PHASE3
• Inactivated Poliomyelitis Vaccine Made From Sabin Strain — COMPLETED · PHASE4
• Clinic Trial to Evaluate the Safety and Immunogenicity by Different Sequential Schedules of bOPV and IPV — COMPLETED · PHASE3
• Consistency Study for Three Commercial Lots of Inactivated Poliomyelitis Vaccine Made From Sabin Strain — COMPLETED · PHASE4
• The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell) — COMPLETED · PHASE2
• Effect of Lactoferrin on Polio Seroconversion — COMPLETED · NA
• A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV — COMPLETED · PHASE3
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults — OTHER · PHASE1
• Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS — COMPLETED · PHASE3
• A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age — COMPLETED · PHASE4
• Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series — OTHER · PHASE2
• Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea — COMPLETED
• Physical Activity in People With Sequelae of Poliomyelitis — OTHER
• A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants — COMPLETED · PHASE4
• An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses — COMPLETED
• Clinical Trial of Novel OPV2 Vaccine — COMPLETED · PHASE2
• Immunogenicity of Intramuscular and Intradermal IPV — TERMINATED · PHASE4

Refine this search